Trial Profile
A Non-Randomized, Open-Label, Two-Part, Drug-Drug Interaction Study to Evaluate the Effects of Cyclosporine and Prednisone on the Pharmacokinetics and Safety of EDP-938 in Healthy Adult Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Sep 2022
Price :
$35
*
At a glance
- Drugs Zelicapavir (Primary) ; Ciclosporin; Prednisone
- Indications Respiratory syncytial virus infections
- Focus Pharmacokinetics
- Sponsors Enanta Pharmaceuticals
- 10 Feb 2019 Status changed from recruiting to completed.
- 26 Nov 2018 New trial record